aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.8239
-0.0039 (-0.47%)
At close: Dec 5, 2025, 4:00 PM EST
0.8200
-0.0039 (-0.47%)
After-hours: Dec 5, 2025, 7:58 PM EST
aTyr Pharma Stock Forecast
ATYR's stock price has decreased by -75.26% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for aTyr Pharma stock ranges from a low of $1.00 to a high of $17. The average analyst price target of $8.75 forecasts a 962.02% increase in the stock price over the next year.
Price Target: $8.75 (+962.02%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for aTyr Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 4 | 4 | 3 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $1.5 → $1 | Hold | Maintains | $1.5 → $1 | +21.37% | Nov 7, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $25 → $1 | Buy → Hold | Downgrades | $25 → $1 | +21.37% | Sep 16, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $16 → $1.5 | Buy → Hold | Downgrades | $16 → $1.5 | +82.06% | Sep 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 15, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $9 → $17 | Strong Buy | Maintains | $9 → $17 | +1,963.36% | Aug 22, 2025 |
Financial Forecast
Revenue This Year
112.20K
from 235.00K
Decreased by -52.26%
Revenue Next Year
21.13M
from 112.20K
Increased by 18,728.88%
EPS This Year
-0.84
from -0.86
EPS Next Year
-0.63
from -0.84
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 409,500 | 123.9M | ||||
| Avg | 112,200 | 21.1M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 74.3% | 110,327.8% | ||||
| Avg | -52.3% | 18,728.9% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.74 | -0.37 | ||||
| Avg | -0.84 | -0.63 | ||||
| Low | -0.92 | -0.80 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.